KARUNA THERAPEUTICS INC (KRTX) Forecast, Price Target & Analyst Ratings

NASDAQ:KRTX • US48576A1007

329.83 USD

+0.09 (+0.03%)

At close: Mar 15, 2024

329.83 USD

0 (0%)

After Hours: 3/15/2024, 8:00:03 PM

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for KARUNA THERAPEUTICS INC (KRTX).

Consensus Price Target

Price Target

$329.12

-0.22% Downside

→ Price target details

Next Earnings Forecast

Earnings Estimate

Release Date: May 2, 2024
Period: Q1 / 2024
EPS Estimate: -$3.03
Revenue Estimate: 3.443M

→ Full earnings forecast details

ChartMill Buy Consensus

Rating

68.70%

Weighted Analyst Rating Score

→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target

$329.12

Upside

-0.22%

From current price of $329.83 to mean target of $329.12, Based on 23 analyst forecasts

Low

$262.60

Median

$336.60

High

$346.50

Price Target Revisions

1 Month

-0.14%

3 Months

21.05%

Price Target Summary

23 Wall Street analysts provided a forecast for the next 12 months for KRTX. The average price target is 329.12 USD. This implies a price decrease of -0.22% is expected in the next year compared to the current price of 329.83.

The average price target has been revised upward by 21.05% in the past 3 months.

→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

Analyst Ratings History

Analyst Ratings Consensus

ChartMill Buy Consensus

68.70%

KRTX was analyzed by 23 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about KRTX.

In the previous month the buy percentage consensus was at a similar level.

KRTX was analyzed by 23 analysts, which should be a sufficient number of analysts to have a meaningful average consensus rating.

→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

Date	Firm	Action	From → To
2024-03-14	HC Wainwright & Co.	Maintains	Neutral -> Neutral
2024-03-11	HC Wainwright & Co.	Reiterate	Neutral -> Neutral
2024-02-20	Cantor Fitzgerald	Reiterate	Neutral -> Neutral
2024-01-26	Mizuho	Downgrade	Buy -> Neutral
2024-01-17	Cantor Fitzgerald	Reiterate	Neutral -> Neutral
2023-12-28	JP Morgan	Downgrade	Overweight -> Neutral
2023-12-26	HC Wainwright & Co.	Downgrade	Buy -> Neutral
2023-12-22	Guggenheim	Downgrade	Buy -> Neutral
2023-12-22	JMP Securities	Downgrade	Market Outperform -> Market Perform
2023-12-22	Wedbush	Downgrade	Outperform -> Neutral
2023-12-22	Morgan Stanley	Downgrade	Overweight -> Equal-Weight
2023-12-12	Deutsche Bank	Initiate	Buy
2023-11-20	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-11-17	JMP Securities	Reiterate	Market Outperform -> Market Outperform
2023-11-17	Wedbush	Reiterate	Outperform -> Outperform
2023-11-03	RBC Capital	Maintains	Outperform -> Outperform
2023-11-03	Wedbush	Maintains	Outperform -> Outperform
2023-11-03	Goldman Sachs	Maintains	Buy -> Buy
2023-09-28	HC Wainwright & Co.	Reiterate	Buy -> Buy
2023-09-08	B of A Securities	Maintains	Buy -> Buy
2023-08-22	Cantor Fitzgerald	Reiterate	Neutral -> Neutral
2023-08-22	Wells Fargo	Initiate	Overweight
2023-08-04	Mizuho	Maintains	Buy -> Buy
2023-08-04	RBC Capital	Maintains	Outperform -> Outperform
2023-08-04	Morgan Stanley	Reiterate	Overweight -> Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date: May 2, 2024
Period: Q1 / 2024
EPS Estimate: -$3.03
Revenue Estimate: 3.443M
Revenue Q2Q: 429.69%
EPS Q2Q: -8.10%
Number of Analysts: 14

Next Earnings Revisions

Revenue (1 Month)

-31.35%

Revenue (3 Months)

-31.35%

EPS (1 Month)

-10.81%

EPS (3 Months)

-9.90%

Next Earnings Summary

KRTX is expected to report earnings on 5/2/2024. The consensus EPS estimate for the next earnings is -3.03 USD and the consensus revenue estimate is 3.44M USD.

The next earnings revenue estimate has been revised downward by 31.35% in the past 3 months. Downward revisions are a negative sign and indicate that analysts are more pessimistic about the next earnings compared to 3 months ago.

→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

	2021	2022	2023	2024	2025	2026	2027	2028	2029	2030
Revenue YoY % growth	36.96M	10.64M -71.21%	654K -93.85%	28.132M 4,201.53%	261.14M 828.27%	742.78M 184.44%	1.479B 99.12%	2.346B 58.62%	3.385B 44.29%	4.108B 21.36%
EBITDA YoY % growth	-143.35M -100.01%	-288.57M -101.30%	-493.076M -70.87%	-509.52M -3.33%	-306.768M 39.79%	17.32M 105.65%	509.39M 2,841.05%	765.61M 50.30%	984.5M 28.59%	1.257B 27.68%
EBIT YoY % growth	-143.86M -100.31%	-289.68M -101.36%	-494.777M -70.80%	-513.609M -3.81%	-351.351M 31.59%	21.145M 106.02%	668.16M 3,059.90%	1.268B 89.77%	2.09B 64.83%	2.664B 27.46%
Operating Margin	-389.23%	-2,722.56%	-75,653.98%	-1,825.71%	-134.54%	2.85%	45.18%	54.05%	61.74%	64.85%
EPS YoY % growth	-4.90 -89.78%	-8.72 -77.96%	-11.72 -34.42%	-12.33 -5.20%	-8.25 33.12%	1.02 112.31%	13.45 1,224.44%	25.27 87.95%	34.48 36.43%	40.91 18.66%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

	Q1 / 24	Q2 / 24	Q3 / 24	Q4 / 24	Q1 / 25	Q2 / 25	Q3 / 25	Q4 / 25
EPS Q2Q % growth	-3.03 -8.10%	-3.22 -17.19%	-3.31 -4.78%	-2.39 20.45%	-2.44 19.46%	-2.15 33.22%	-1.84 44.57%	-1.47 38.45%
Revenue Q2Q % growth	3.443M 429.69%	22.95K	4.003M	19.51M	20.934M 508.02%	33.047M 143,895.64%	45.196M 1,029.05%	58.078M 197.68%
EBITDA Q2Q % growth	-118.949M -9.39%	-127.512M -7.05%	-131.916M 2.26%	-131.256M -2.64%	-143.004M -20.22%	-135.048M -5.91%	-127.908M 3.04%	-117.912M 10.17%
EBIT Q2Q % growth	-125.935M -15.46%	-134.98M -12.57%	-139.689M -2.55%	-88.105M 32.01%	-143.718M -14.12%	-136.374M -1.03%	-129.948M 6.97%	-120.666M -36.96%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year

27.79%

EPS Next 5 Year

32.97%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year

680.54%

Revenue Next 5 Year

331.85%

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year

26.73%

EBIT Next 5 Year

28.98%

→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

KARUNA THERAPEUTICS INC / KRTX Forecast FAQ

What is the average price target for KARUNA THERAPEUTICS INC (KRTX) stock?

23 analysts have analysed KRTX and the average price target is 329.12 USD. This implies a price decrease of -0.22% is expected in the next year compared to the current price of 329.83.

Can you provide the upcoming earnings date for KARUNA THERAPEUTICS INC?

KARUNA THERAPEUTICS INC (KRTX) will report earnings on 2024-05-02, after the market close.

Can you provide the consensus estimates for KARUNA THERAPEUTICS INC next earnings?

The consensus EPS estimate for the next earnings of KARUNA THERAPEUTICS INC (KRTX) is -3.03 USD and the consensus revenue estimate is 3.44M USD.

What is the expected long term growth rate for KARUNA THERAPEUTICS INC (KRTX)?

The expected long term growth rate for KARUNA THERAPEUTICS INC (KRTX) is 680.54%.

Analyst forecast overview

Forecast Snapshot